Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 12/20 | 0.36 |
| ▸ | PDE4A | P27815 | 6/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 6/20 | 0.36 |
| ▸ | PDE4C | Q08493 | 6/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29830733 | 0.84 | PDE4D (0.45) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL17517935 | 0.81 | CTSL (0.36) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL25399653 | 0.81 | NAAA (0.34) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL8230175 | 0.80 | PDE4D (0.38) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL13351589 | 0.80 | PDE4D (0.38) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL13351557 | 0.80 | PDE4D (0.38) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL22857739 | 0.79 | NAAA (0.64) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL29830900 | 0.79 | NAAA (0.64) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL28966316 | 0.79 | NAAA (0.64) | NAAAPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL29830580 | 0.79 | NAAA (0.64) | NAAAPDE4DPDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024024935-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE HAVING ANTINEOPLASTIC EFFECT | 第一三共株式会社 | 2024-02-01 | — | — | WO | disclosed |